Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 May;64(2):423–431.

Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.

R Greil, C Gattringer, T Schulz, W Knapp, T Radaskiewicz, M P Dierich, H Huber
PMCID: PMC1542352  PMID: 2943542

Abstract

In the majority of 188 non-Hodgkin lymphomas (NHL) investigated in this study, we found a simultaneous expression of the receptors for c3b and c3d (CR1 & CR2; cccorr = 0.69, P less than 0.0005). An analysis of the different histological entities of the Kiel classification revealed that this coexpression was most pronounced for germinal centre-derived (cccorr = 0.63, P = 0.0004) and immunocytic NHL (cccorr = 0.86, P = 0.0024), whereas in chronic lymphocytic leukaemias there tended to be a more heterogeneous pattern of complement receptor (CR) expression (cccorr = 0.29, P greater than 0.10). In contrast to these NHL of mid B cell stage, most of the NHL of early (i.e. acute lymphocytic leukaemia, lymphoblastic NHL) and late B cell stage (i.e. hairy cell leukaemia, immunoblastic NHL, multiple myeloma) did not express either of these receptors. CR positive NHL often showed a follicular arrangement of the neoplastic cells and had higher numbers of T helper/inducer (T4) lymphocytes (PCR1 less than 0.00005, PCR2 less than 0.05). Some cases of mid B cell NHL and all cases of hairy cell leukaemia reacted with antibodies against CR3 (i.e. the ic3b receptor).

Full text

PDF
423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. C., Bates M. P., Slaughenhoupt B. L., Pinkus G. S., Schlossman S. F., Nadler L. M. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984 Jun;63(6):1424–1433. [PubMed] [Google Scholar]
  2. Bhan A. K., Nadler L. M., Stashenko P., McCluskey R. T., Schlossman S. F. Stages of B cell differentiation in human lymphoid tissue. J Exp Med. 1981 Sep 1;154(3):737–749. doi: 10.1084/jem.154.3.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bofill M., Janossy G., Janossa M., Burford G. D., Seymour G. J., Wernet P., Kelemen E. Human B cell development. II. Subpopulations in the human fetus. J Immunol. 1985 Mar;134(3):1531–1538. [PubMed] [Google Scholar]
  4. Chilosi M., Pizzolo G., Caligaris-Cappio F., Ambrosetti A., Vinante F., Morittu L., Bonetti F., Fiore-Donati L., Janossy G. Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. Cancer. 1985 Jul 15;56(2):328–332. doi: 10.1002/1097-0142(19850715)56:2<328::aid-cncr2820560221>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  5. Chilosi M., Pizzolo G., Fiore-Donati L., Bofill M., Janossy G. Routine immunofluorescent and histochemical analysis of bone marrow involvement of lymphoma/leukaemia: the use of cryostat sections. Br J Cancer. 1983 Dec;48(6):763–775. doi: 10.1038/bjc.1983.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Corbel C., Melchers F. Requirement for macrophages or for macrophage- or T cell-derived factors in the mitogenic stimulation of murine B lymphocytes by lipopolysaccharides. Eur J Immunol. 1983 Jul;13(7):528–533. doi: 10.1002/eji.1830130703. [DOI] [PubMed] [Google Scholar]
  7. Daha M. R., Bloem A. C., Ballieux R. E. Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies. J Immunol. 1984 Mar;132(3):1197–1201. [PubMed] [Google Scholar]
  8. Dierich M. P., Landen B. Complement bridges between cells analysis of a possible cell-cell interaction mechanism. J Exp Med. 1977 Dec 1;146(6):1484–1499. doi: 10.1084/jem.146.6.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eddy A., Newman S. L., Cosio F., LeBien T., Michael A. The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibody. Clin Immunol Immunopathol. 1984 Jun;31(3):371–389. doi: 10.1016/0090-1229(84)90090-4. [DOI] [PubMed] [Google Scholar]
  10. Erdei A., Melchers F., Schulz T., Dierich M. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol. 1985 Feb;15(2):184–188. doi: 10.1002/eji.1830150214. [DOI] [PubMed] [Google Scholar]
  11. Fearon D. T. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867–5871. doi: 10.1073/pnas.76.11.5867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Foon K. A., Schroff R. W., Gale R. P. Surface markers on leukemia and lymphoma cells: recent advances. Blood. 1982 Jul;60(1):1–19. [PubMed] [Google Scholar]
  13. Frade R., Barel M., Ehlin-Henriksson B., Klein G. gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1490–1493. doi: 10.1073/pnas.82.5.1490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Frade R., Crevon M. C., Barel M., Vazquez A., Krikorian L., Charriaut C., Galanaud P. Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule. Eur J Immunol. 1985 Jan;15(1):73–76. doi: 10.1002/eji.1830150114. [DOI] [PubMed] [Google Scholar]
  15. Gattringer C., Huber H., Radaszkiewicz T., Pfaller W., Braunsteiner H. Imbalance of helper and suppressor T lymphocytes in malignant non-Hodgkin lymphomas: an in situ morphometric analysis. Int J Cancer. 1984 Jun 15;33(6):751–757. doi: 10.1002/ijc.2910330607. [DOI] [PubMed] [Google Scholar]
  16. Gattringer C., Radaszkiewicz T., Pfaller W., Huber H. Infiltration density of HNK 1 positive cells in non-Hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis. Immunobiology. 1985 Apr;169(3):280–291. doi: 10.1016/S0171-2985(85)80040-1. [DOI] [PubMed] [Google Scholar]
  17. Gerdes J., Naiem M., Mason D. Y., Stein H. Human complement (C3b) receptors defined by a mouse monoclonal antibody. Immunology. 1982 Apr;45(4):645–653. [PMC free article] [PubMed] [Google Scholar]
  18. Greil R., Gattringer C., Knapp W., Huber H. Growth fraction of tumour cells and infiltration density with natural killer-like (HNK1+) cells in non-Hodgkin lymphomas. Br J Haematol. 1986 Feb;62(2):293–300. doi: 10.1111/j.1365-2141.1986.tb02932.x. [DOI] [PubMed] [Google Scholar]
  19. Hammann K. P., Scheiner O., Schulz T., Erdei A., Dierich M. P. Binding of the third component of complement (C3) to Thy-1.2 positive Con-A-induced blasts of the murine spleen: modulation of the C3 binding and cell aggregation by protease inhibitors. Immunology. 1983 Mar;48(3):415–422. [PMC free article] [PubMed] [Google Scholar]
  20. Hartmann K. U., Bokisch V. A. Stimulation of murine B lymphocytes by isolated C3b. J Exp Med. 1975 Sep 1;142(3):600–610. doi: 10.1084/jem.142.3.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Huber H., Gattringer C., Knapp W., Stein H. Immunopathology of non-Hodgkin lymphomas. Klin Wochenschr. 1984 Nov 2;62(21):1001–1010. doi: 10.1007/BF01711721. [DOI] [PubMed] [Google Scholar]
  22. Iida K., Nussenzweig V. Functional properties of membrane-associated complement receptor CR1. J Immunol. 1983 Apr;130(4):1876–1880. [PubMed] [Google Scholar]
  23. Klaus G. G., Humphrey J. H., Kunkl A., Dongworth D. W. The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol Rev. 1980;53:3–28. doi: 10.1111/j.1600-065x.1980.tb01038.x. [DOI] [PubMed] [Google Scholar]
  24. Klaus G. G., Humphrey J. H. The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology. 1977 Jul;33(1):31–40. [PMC free article] [PubMed] [Google Scholar]
  25. Lobo P. I., Burge J. J. In vitro studies on the immune regulatory role of complement receptors (C3) present on human B lymphocytes. Eur J Immunol. 1982 Aug;12(8):682–686. doi: 10.1002/eji.1830120811. [DOI] [PubMed] [Google Scholar]
  26. Melchers F., Erdei A., Schulz T., Dierich M. P. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature. 1985 Sep 19;317(6034):264–267. doi: 10.1038/317264a0. [DOI] [PubMed] [Google Scholar]
  27. Mitchell J., Pye J., Holmes M. C., Nossal G. J. Antigens in immunity. Antigen localization in congenitally athymic "nude" mice. Aust J Exp Biol Med Sci. 1972 Oct;50(5):637–650. doi: 10.1038/icb.1972.56. [DOI] [PubMed] [Google Scholar]
  28. Nadler L. M., Stashenko P., Hardy R., van Agthoven A., Terhorst C., Schlossman S. F. Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol. 1981 May;126(5):1941–1947. [PubMed] [Google Scholar]
  29. Papamichail M., Gutierrez C., Embling P., Johnson P., Holborow E. J., Pepys M. B. Complement dependence of localisation of aggregated IgG in germinal centres. Scand J Immunol. 1975;4(4):343–347. doi: 10.1111/j.1365-3083.1975.tb02635.x. [DOI] [PubMed] [Google Scholar]
  30. Pepys M. B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med. 1974 Jul 1;140(1):126–145. doi: 10.1084/jem.140.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pepys M. B. Role of complement in induction of the allergic response. Nat New Biol. 1972 May 31;237(74):157–159. doi: 10.1038/newbio237157a0. [DOI] [PubMed] [Google Scholar]
  32. Pizzolo G., Chilosi M. Double immunostaining of lymph node sections by monoclonal antibodies using phycoerythrin labeling and haptenated reagents. Am J Clin Pathol. 1984 Jul;82(1):44–47. doi: 10.1093/ajcp/82.1.44. [DOI] [PubMed] [Google Scholar]
  33. Radzun H. J., Parwaresch M. R. Differential immunohistochemical resolution of the human mononuclear phagocyte system. Cell Immunol. 1983 Nov;82(1):174–183. doi: 10.1016/0008-8749(83)90151-x. [DOI] [PubMed] [Google Scholar]
  34. Ramos O. F., Sármay G., Klein E., Yefenof E., Gergely J. Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5470–5474. doi: 10.1073/pnas.82.16.5470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ross G. D., Lambris J. D., Cain J. A., Newman S. L. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity. J Immunol. 1982 Nov;129(5):2051–2060. [PubMed] [Google Scholar]
  36. Ross G. D., Medof M. E. Membrane complement receptors specific for bound fragments of C3. Adv Immunol. 1985;37:217–267. doi: 10.1016/s0065-2776(08)60341-7. [DOI] [PubMed] [Google Scholar]
  37. Rutherford B., Schenkein H. A. C3 cleavage products stimulate release of prostaglandins by human mononuclear phagocytes in vitro. J Immunol. 1983 Feb;130(2):874–877. [PubMed] [Google Scholar]
  38. Schulz T. F., Scharfenberger H., Lambris J. D., Rieber P., Riethmüller G., Dierich M. P. Antigenic relationship between the alpha-chain of C3, a leucocyte-surface antigen involved in the activation of phagocytic cells, and a 50,000 MW B-cell antigen. Immunology. 1985 Apr;54(4):791–800. [PMC free article] [PubMed] [Google Scholar]
  39. Tedder T. F., Clement L. T., Cooper M. D. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol. 1984 Aug;133(2):678–683. [PubMed] [Google Scholar]
  40. Tedder T. F., Fearon D. T., Gartland G. L., Cooper M. D. Expression of C3b receptors on human be cells and myelomonocytic cells but not natural killer cells. J Immunol. 1983 Apr;130(4):1668–1673. [PubMed] [Google Scholar]
  41. Tsan M. F., McIntyre P. A. Stimulation by propylthiouracil of the hexose monophosphate shunt in human polymorphonuclear leucocytes during phagocytosis. Br J Haematol. 1975 Oct;31(2):193–208. doi: 10.1111/j.1365-2141.1975.tb00850.x. [DOI] [PubMed] [Google Scholar]
  42. Whisler R. L., Newhouse Y. G., Lachman L. B. Heterogeneity of human monocyte subsets in the promotion of B cell colonies and the role of interleukin 1. J Immunol. 1982 Aug;129(2):455–460. [PubMed] [Google Scholar]
  43. White R. G., Henderson D. C., Eslami M. B., Neilsen K. H. Localization of a protein antigen in the chicken spleen. Effect of various manipulative procedures on the morphogenesis of the germinal centre. Immunology. 1975 Jan;28(1):1–21. [PMC free article] [PubMed] [Google Scholar]
  44. Wright S. D., Rao P. E., Van Voorhis W. C., Craigmyle L. S., Iida K., Talle M. A., Westberg E. F., Goldstein G., Silverstein S. C. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5699–5703. doi: 10.1073/pnas.80.18.5699. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES